American Society For Transplantation And Cellular Therapy | WebDisclosure

Basculer en Français

8201	Companies
109005	Keywords
51275	Articles
60079	Press releases

Headlines Articles Press releases American Society For Transplantation And Cellular Therapy

Home
Companies
American Society For Transplantation And Cellular Therapy

BRIEF

published on 08/15/2024 at 19:05, 2 months 18 days ago

La FDA approuve l'axatilimab-Csfr pour le traitement de la maladie chronique du greffon contre l'hôte

ASTCT Approbation De La FDA Axatilimab-csfr Traitement De La GVHD Chronique Etude AGAVE-201
BRIEF

published on 08/15/2024 at 19:05, 2 months 18 days ago

FDA Approves Axatilimab-Csfr for Chronic Graft-Versus-Host Disease

FDA Approval ASTCT Axatilimab-csfr CGVHD Treatment AGAVE-201 Study
PRESS RELEASE

published on 08/15/2024 at 19:00, 2 months 18 days ago

ASTCT Applauds FDA Approval of Axatilimab-Csfr for the Treatment of Chronic Graft-Versus-Host Disease (cGVHD)
ASTCT applauds FDA approval of Niktimvo by Incyte Corporation for cGVHD treatment. Study confirms efficacy and potential benefits for patients. ASTCT remains committed to advancing transplantation field

FDA Approval ASTCT Transplantation CGVHD Treatment Niktimvo
BRIEF

published on 08/02/2024 at 22:15, 3 months ago

La FDA approuve TECELRA pour le traitement du sarcome synovial

ASTCT Thérapie Cellulaire Approbation De La FDA TECELRA Sarcome Synovial
BRIEF

published on 08/02/2024 at 22:15, 3 months ago

FDA Approves TECELRA for Synovial Sarcoma Treatment

FDA Approval Cellular Therapy ASTCT Synovial Sarcoma TECELRA
PRESS RELEASE

published on 08/02/2024 at 22:10, 3 months ago

American Society for Transplantation and Cellular Therapy Applauds FDA Approval of TECELRA(R) for Synovial Sarcoma Treatment
The FDA's accelerated approval of TECELRA marks a milestone in cancer treatment. ASTCT supports this advance in cellular therapy for synovial sarcoma patients

FDA Approval Cellular Therapy ASTCT Synovial Sarcoma TECELRA
BRIEF

published on 04/10/2024 at 16:05, 6 months 22 days ago

L'ASTCT approuve les nouvelles approbations de thérapie cellulaire CAR T de la FDA pour le myélome multiple

Innovation Médicale Approbation De La FDA Myélome Multiple Thérapie Cellulaire CAR T Approbation De L'ASTCT
BRIEF

published on 04/10/2024 at 16:05, 6 months 22 days ago

ASTCT Endorses FDA's New CAR T-Cell Therapy Approvals for Multiple Myeloma

FDA Approval Medical Innovation Multiple Myeloma CAR T-cell Therapy ASTCT Endorsement
PRESS RELEASE

published on 04/10/2024 at 16:00, 6 months 22 days ago

ASTCT Supports the FDA's Approval of Earlier Use of CAR T-Cell Therapy for Multiple Myeloma
FDA approves expanded use of CAR T-Cell therapies Abecma and Carvykti for multiple myeloma treatment, supported by ASTCT. Decision based on FDA and ODAC recommendations

FDA Approval Multiple Myeloma CAR T-cell Therapy ASTCT Support Disease Intervention
BRIEF

published on 03/22/2024 at 16:05, 7 months 11 days ago

Medicare Expands Stem Cell Transplant Coverage for Myelodysplastic Syndromes

Medicare Stem Cell Transplantation Health Policy Myelodysplastic Syndromes National Coverage Determination

Accesswire

Published on 11/03/2024 at 00:45, 12 hours 18 minutes ago

Holtway Global Hedge Expands into Europe, Providing Exclusive Pre-IPO and IPO Access to Companies Led by Visionary Founders like Elon Musk and Sam Altman
Published on 11/02/2024 at 19:15, 17 hours 48 minutes ago

Hank Payments Announces Closing of Financing and Settlements
Published on 11/02/2024 at 16:10, 20 hours 53 minutes ago

Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/02/2024 at 14:30, 22 hours 33 minutes ago

Spa Sciences Health Introduces Revolutionary Nasal Irrigation System at CVS
Published on 11/02/2024 at 00:48, 1 day 12 hours ago

OneSoft Solutions Inc. Announces the Completion of Its Acquisition by Irth Solutions LLC, a Blackstone Portfolio Company

View all ACCESSWIRE

EQS Group

Published on 11/01/2024 at 21:31, 1 day 15 hours ago

Original-Research: Telefonica Deutschland Holding AG (von First Berlin Equity Research GmbH): Buy
Published on 11/01/2024 at 18:18, 1 day 18 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/01/2024 at 17:47, 1 day 19 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/01/2024 at 17:10, 1 day 19 hours ago

EQS-Adhoc: fox e-mobility AG: provisional debt restructuring moratorium of Fox Automotive Switzerland AG
Published on 11/01/2024 at 16:00, 1 day 21 hours ago

Total Voting Rights

Les Echos

Published on 10/31/2024 at 20:26, 2 days 16 hours ago

I.CERAM - Résultat du 1er semestre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Déclaration hebdomadaire d'opérations effectuées du 28 au 31 octobre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Disclosure of transactions in own shares on October 28 to October 31, 2024
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2024 : +3%
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION: THIRD QUARTER 2024 TURNOVER UP 3%

View all LES ECHOS COMFI WIRE